Skip to main
ALHC

Alignment Healthcare (ALHC) Stock Forecast & Price Target

Alignment Healthcare (ALHC) Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 30%
Buy 50%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

Alignment Healthcare Inc. is strategically positioned to capitalize on the anticipated stronger 2026 Medicare Advantage rate update, particularly as many managed care organizations reduce benefits, allowing Alignment to leverage its Stars funding advantage. The company’s integrated Medicare Advantage-Value-Based Care model is expected to facilitate long-term market share growth and robust revenue expansion. Additionally, the projected gross profit per member per month for year one to two cohorts is estimated to range from $90 to $150, with significant potential to increase to over $230 in years three to five, indicating a favorable financial trajectory and the possibility of enhanced membership growth and margin maturation.

Bears say

Alignment Healthcare Inc. has faced challenges with its value-based care (VBC) model, including data friction among various payors, which could hinder operational efficiency and affect financial performance. Although the company has successfully driven its Average Daily Kiss (ADK) lower in a high-utilization environment, it must navigate these inherent disadvantages to sustain its growth trajectory. Furthermore, despite prioritizing technological advancements and reporting positive EBITDA growth, Alignment Healthcare's valuation multiple remains positioned slightly above the long-term range for peer managed care organizations, suggesting potential concerns over future financial sustainability.

Alignment Healthcare (ALHC) has been analyzed by 10 analysts, with a consensus rating of Buy. 30% of analysts recommend a Strong Buy, 50% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Alignment Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Alignment Healthcare (ALHC) Forecast

Analysts have given Alignment Healthcare (ALHC) a Buy based on their latest research and market trends.

According to 10 analysts, Alignment Healthcare (ALHC) has a Buy consensus rating as of Jan 10, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.15, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.15, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Alignment Healthcare (ALHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.